Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. Receive Approval For Cetrotide
4/21/2006 10:30:48 AM
More...
|
AEterna Laboratories Inc. (AELA) / Zentaris GmbH (AELA) To Present Today Additional Detailed Positive Phase II Data On Cetrorelix In Gynecological Indications At The 18th World Congress Of The International Federation Of Fertility Societies (IFFS)
10/19/2005 5:11:29 PM
More...
|
Spectrum Pharmaceuticals (SPPI) Licenses A Fourth-Generation Phase 2 LHRH Antagonist From Zentaris GmbH (AELA)
10/19/2005 5:11:07 PM
More...
|
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris AG (AELA) To Present Final Results From Phase I Trial Of Perifosine In Combination With Radiotherapy At 2004 American Society of Clinical Oncology Annual Meeting
10/19/2005 5:10:44 PM
More...
|
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris AG (AELA) Signs New Agreement With Ardana Bioscience For LHRH Antagonist Teverelix
10/19/2005 5:10:40 PM
More...
|
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris AG (AELA) Reports Positive Preclinical Results From Novel Pyrazole Compound - Results Indicate ZEN-014 As A New Candidate For The Development Of A Potent Anticancer Drug
10/19/2005 5:10:38 PM
More...
|
AEterna Laboratories Inc. (AELA) Expands Pipeline As Zentaris Subsidiary Establishes New Research Collaborations With University Laboratories In France, Germany And Italy
10/19/2005 5:10:25 PM
More...
|
AEterna Laboratories Inc. (AELA) Through Its Subsidiary Zentaris GmbH (AELA) Signs Partnership With Roche (RHHBY) In Brazil For New Treatment Of Leishmaniasis, A Devastating Tropical Disease
10/19/2005 5:09:52 PM
More...
|
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris AG (AELA) And Solvay Pharmaceuticals, Inc. Sign Extensive Collaboration Agreement
10/19/2005 5:09:47 PM
More...
|